Erik Harris, EVP & Chief Commercial Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 375 shares at $91.53 ($34K) on 2021-07-06, disclosed to the SEC on 2021-07-08.
Open-market sale of $34k RARE by EVP & Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| RARE | SELL | 2024-03-05 | $513K | — | Filing → |
| RARE | SELL | 2023-09-06 | $228K | — | Filing → |
| RARE | SELL | 2023-06-21 | $15K | — | Filing → |